Evaluating cellular uptake of gold nanoparticles in HL-7702 and HepG2 cells for plasmonic photothermal therapy by Wang, Peng et al.
Citation: Wang, Peng, Wu, Qiang, Wang, Fuyan, Zhang, Yaping, Jiang, Tao, Gu, Chenjie, 
Huang, Shuiping,  Wang, Hongxi,  Bu, Shizhong and Zhou, Jun (2018) Evaluating cellular 
uptake  of  gold  nanoparticles  in  HL-7702  and  HepG2  cells  for  plasmonic  photothermal 
therapy. Nanomedicine, 13 (18). pp. 2245-2259. ISSN 1743-5889 
Published by: Future Science Group
URL: https://doi.org/10.2217/nnm-2018-0126 <https://doi.org/10.2217/nnm-2018-0126>
This  version  was  downloaded  from  Northumbria  Research  Link: 
http://nrl.northumbria.ac.uk/35998/
Northumbria University has developed Northumbria Research Link (NRL) to enable users to 
access the University’s research output. Copyright ©  and moral rights for items on NRL are 
retained by the individual author(s) and/or other copyright owners.  Single copies of full items 
can be reproduced,  displayed or  performed,  and given to third parties in  any format  or 
medium for personal research or study, educational, or not-for-profit purposes without prior 
permission or charge, provided the authors, title and full bibliographic details are given, as 
well  as a hyperlink and/or URL to the original metadata page.  The content must  not  be 
changed in any way. Full  items must not be sold commercially in any format or medium 
without  formal  permission  of  the  copyright  holder.   The  full  policy  is  available  online: 
http://nrl.northumbria.ac.uk/policies.html
This document may differ from the final, published version of the research and has been 
made available online in accordance with publisher policies. To read and/or cite from the 
published version of the research, please visit the publisher’s website (a subscription may be 
required.)
Research Article
For reprint orders, please contact: reprints@futuremedicine.com
Evaluating cellular uptake of gold
nanoparticles in HL-7702 and HepG2 cells for
plasmonic photothermal therapy
Peng Wang1, Qiang Wu2, Fuyan Wang3, Yaping Zhang4, Liying Tong1, Tao Jiang1, Chenjie
Gu1, Shuiping Huang1, Hongxi Wang5, Shizhong Bu3 & Jun Zhou*,1
1Faculty of Science, Institute of Photonics, Ningbo University, Ningbo 315211, Zhejiang, China
2Department of Mathematics, Physics & Electrical Engineering, Northumbria University, Newcastle upon Tyne, NE1 8ST, UK
3Zhejiang Provincial Key Laboratory of Pathophysiology School of Medicine, Ningbo University, Ningbo 315211, Zhejiang, China
4Department of Electrical & Electronic Engineering, University of Nottingham Ningbo China, Ningbo 315100, China
5Science Department, Zhenhai High School of Zhejiang, Ningbo 315200, China
*Author for correspondence: Tel.:+86 574 8760 0794; Fax: +86 574 8760 0744; zhoujun@nbu.edu.cn
Aim: A novel methodology is provided to quantitatively measure the gold (Au) mass internalized in a cell
for effective implementation of plasmonic photothermal therapy (PPTT).Materials & methods: The cellu-
lar uptake of 4-mercaptobenzoic acid-labeled Au nanoparticles (NPs) is investigated via Raman mapping
and inductively coupled plasma-mass spectrometry and the efficiency of in vitro PPTT is evaluated. Results
& conclusion: The cellular uptake is strongly affected by the size of the Au NPs, concentration of the Au
NPs, incubation time and cell type. By optimizing the experimental parameters, the results show that a
significant damage is caused to the HepG2 cells and slight harm is caused to the HL-7702 cells during PPTT.
This demonstrates a high potential for developing effective photothermal therapy for tumor tissues.
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A novel method is proposed for quantifying the Raman intensity as a function of gold mass in a single
cell based on the Raman mapping and inductively coupled plasma-mass spectrometry techniques. And a
high-efficiency plasmonic photothermal therapy has also been achieved by adjusting the laserwavelength,
laser power and exposure time, resulting in most of the HL-7702 cells survive, whereas most of the HepG2
cells get damaged.
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Plasmonic photothermal therapy (PPTT) has attracted an increasing attention as a noninvasive method for its
application in the treatment of cancer [1,2]. In the process of PPTT, when the plasmonic nanoparticles (NPs)
internalized in the tumor tissues are irradiated by a laser, the oscillation of electrons in the conduction band of
the plasmonic NPs, in other words, the surface plasmon oscillation, is excited, thus simultaneously absorbing and
scattering the laser light and resulting in the conversion of the absorbed light to heat to kill the cancer cells [3–5]. To
achieve high-efficiency PPTT, various functional plasmonic NPs have been developed in the past [6,7]. For example,
synthesized polygonal gold (Au) NPs were bonded with vancomycin as photothermal agents to kill the bacteria
by irradiating of near-infrared (NIR) light [8]. Au nanorods conjugated with polydopamine were coated by EGF
receptor antibodies for cancer cell-targeted imaging and photothermal therapy by NIR light [9]. Biodegradable
liposome–Au NPs were used to ablate the mouse tumor xenograft by illuminating with an NIR laser of 750 nm
wavelength [10]. In ideal PPTT, the cancer cells are expected to be destroyed completely with the normal cells
surviving without any damage. To achieve this objective, a direct solution is the internalization of more plasmonic
NPs into the cancer cells and fewer plasmonic NPs into the normal cells, which will excite strong oscillation of
surface plasmon polaritons in the cancer cells, resulting in a significant conversion of light to heat to damage the
cancer cells. Therefore, it is important to investigate the cellular uptake processes of plasmonic NPs for both cancer
and normal cells.
Various advanced technologies have been used to investigate the cellular uptake of plasmonic NPs [11]. Dark field
microscopy and transmission electron microscopy (TEM) were combined to quantify the number of Au NPs and
locate the Au NPs in the cell [12]. A focused ion beam/scanning electron microscopy (SEM) slice and view approach
was presented to systematically analyze the cellular uptake of silver NPs in an individual human macrophage [13].
Multiple techniques such as photon cross-correlation spectroscopy, lactate dehydrogenase, Alamar blue assay and
TEM were adopted to assess the toxicity and cellular uptake of Ag NPs in human lung cells (BEAS-2B) [14].
However, these sophisticated techniques require extensive and time-consuming sample preparation for quantifying
the cellular uptake of plasmonic NPs [15]. As a highly sensitive elemental analysis technology, inductively coupled
plasma-mass spectrometry (ICP-MS) is usually used for accurately determining the mass of metal or metal oxide
NPs internalized in cells [16]. In addition, as a noninvasive imaging technique, Raman mapping has been widely
applied in molecular detection and cell imaging with a high spatial resolution [17]. Clearly, by combining the
advantages of ICP-MS and Raman mapping, the process of cellular uptake in cells can be quantitatively measured,
which is important for developing controllable and highly efficient PPTT.
In our work, the cancerous (HepG2) hepatic cells and normal (HL-7702) are respectively chosen as typical
cancer sample and a control sample because of the serious threat of liver cancer. And 4-mercaptobenzoic acid
(4MBA) as Raman molecule was linked with the Au NPs to form 4MBA-labeled Au NPs, due to its distinct Raman
characteristic and low cytotoxicity [18]. The surface-enhanced Raman scattering (SERS) signal of 4MBA was used
to evaluate the cellular uptake for HL-7702 and HepG2 cells by combining of Raman mapping and ICP-MS
techniques for achieving high-efficiency PPTT. During the co-culture period of the cells and 4MBA-labeled Au
NPs, we found that the Au mass in the cells increased with an increasing incubation time and size and concentration
of the Au NPs. The Au mass internalized in the HepG2 cells was much larger than that in the HL-7702 cells.
Particularly, when the size and concentration of the Au NPs were 35 nm and 50 μg/ml, respectively, the ratio of the
Au mass in the HL-7702 cells to that in the HepG2 cells reached an optimal value of 9.08 for an incubation time
of 16 h. Moreover, the cytotoxicity of the Au NPs was evaluated using methyl thiazolyl tetrazolium (MTT) assays
for analyzing the cell viabilities of the HL-7702 and HepG2 cells. Subsequently, in vitro PPTT experiments were
conducted using the different laser wavelengths, laser powers and exposure times. Our results showed that under
the optimal values of 566 W/cm2 of irradiated intensity, 4 min of exposure time and 532 nm of laser wavelength,
65% HepG2 cells were killed, whereas 73.8% HL-7702 cells still survived. This demonstrated that cellular uptake
of Au NPs was the key for realizing high-efficiency PPTT for the in vivo treatment of tumors.
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Materials & methods
Materials
Tetrachloroauric acid (HAuCl4 · 3H2O), MTT, dimethyl sulfoxide, paraformaldehyde and phosphate buffer
solution (PBS; pH = 7.0) were purchased from Sigma-Aldrich Corporation, USA. Trisodium citrate dehydrate
(C6H5Na3O7 · 2H2O) was purchased from Tianjin Bodi Chemical Reagents Co. Ltd, China. 4MBA was obtained
from Tokyo Chemical Industry Co. Ltd, Japan. Human hepatic immortalized cell lines (HL-7702) and human
hepatocellular carcinoma cell lines (HepG2) were obtained from the Shanghai Cell Bank of the Chinese Academy
of Sciences, China. Dulbecco’s modified Eagle’s medium, fetal bovine serum, penicillin and streptomycin were
purchased from Shanghai Excell Biotechnology Co. Ltd, China. 24 well plates and cell climbing slices were
purchased from Ningbo Hangjing Biotechnology Co. Ltd, China. Pancreatin was purchased from Shanghai Biyun
Tian Biotechnology Co. Ltd, China. Milli-Q water (resistivity of 18.2 M · cm−1) was used for the preparation
of all the solutions. All the glassware used were cleaned by freshly prepared aqua regia solution (HCl: HNO3; 3:1)
before the synthesis of the NPs. In addition, all the solutions were sterilized prior to the cell experiments.
Synthesis of citrate-capped gold nanoparticles labeled with 4-mercaptobenzoic acid
Au NPs were synthesized using Frens’ modified method [19]. Initially, 500 ml of de-ionized water was equally
injected into five Erlenmeyer flasks; then 1 ml of HAuCl4 (25.38 mM/l) was added to each flask. Second, the
HAuCl4 solutions in the flasks were heated to boiling; then, different amounts of sodium citrate (2, 1, 0.9, 0.7 and
0.5 ml, 0.039 M/l) were injected separately into the flasks with vigorous agitation for 20 min. Finally, the color
of the solutions changed from dark blue to wine red, in other words, different sizes of Au NPs (20, 30, 35, 45
and 60 nm) were synthesized. After cooling to 20◦C, the as-prepared Au NP solutions (2 ml) were centrifuged at
10,000 rpm for 20 min and the precipitates of the Au NPs were re-dispersed in 2 ml of de-ionized water.
The modification of Au NPs was performed with 4MBA. Briefly, 20 μL of 4MBA (10 mM/l) was separately
added to the above purified Au NP solutions under stirring and the mixed solutions were agitated for 8 h. Then
the resultant solutions were centrifuged at 10,000 rpm for 20 min to remove unbound 4MBA molecules. Finally,
the sediments were re-dispersed in 2 ml of de-ionized water to form the 4MBA-labeled Au NP solutions to be used
in the subsequent experiments.
Cell culture
Both the HL-7702 and HepG2 cells were cultured in a regular growth medium composed of Dulbecco’s modified
Eagle’s medium supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin at 37◦C in a humidified
environment containing 5% CO2.
Quantification of gold mass & Raman intensity
First, the HL-7702 and HepG2 cells were separately seeded on 24-well plates at a density of 1 × 105 cells/well and
then, the cells were cultured for 24 h to achieve the logarithmic growth of the cells. Second, 200 μl of 4MBA-labeled
Au NPs solution was added to each well of the 24-well plates and then the cells were incubated for 2, 4, 6, 8, 12,
16, 20 and 24 h, respectively. Next, the mixture medium in each well was pipetted and the cell climbing slice was
washed twice by PBS. Subsequently, 200 μl of pancreatin (2000 BAEE u/ml) was injected into each well to digest
the cells for 2 min and 20 μ of the cell solution was pipetted for cell counting using a cytometer. Last, the cells
remaining in the 24-well plates were fixed by 0.4% paraformaldehyde (100 μl/well) for 30 min and dried at 20◦C.
The quantifying relation between Au mass and Raman intensity of 4MBA in a single cell was obtained by
the following steps. First, Raman spectra of the cell samples were measured by the scanning near-field optical
microscope (SNOM) system with the parameters of 633 nm wavelength, 50 mW power and 2s integration time.
Raman mapping images were obtained by scanning the cell samples and the integral of the Raman peaks at 1393
or 1576 cm-1 was recorded as the intensity of each pixel. Next, the Raman mapping image corresponding to the
Raman peaks at 1393 cm-1 was reproduced by our self-written MATLAB program to obtain the cellular outlines
with coordinates. Subsequently, from the Raman mapping image corresponding to the Raman peaks at 1576 cm-1,
the total Raman intensities in every cell were obtained by summing the Raman intensities of all the pixels in the
cellular outlines. Next, the sum of the total Raman intensities in every cell was divided by the total number of cells
in the image to obtain the average Raman intensity in a single cell. In addition, after the cell climbing slice was
dissolved by aqua regia solution, the Au mass in the cells was measured by ICP-MS. Then, the measured Au mass
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was divided by the number of cells to obtain the Au mass per cell. Finally, for the HL-7702 and HepG2 cells, we
set the relation between the Au mass per cell and average Raman intensity of the peaks at 1576 cm-1.
Cellular uptake of gold NPs
The cellular uptake of the Au NPs was investigated by varying their size and concentration during the incubation
of the cells. First, the HL-7702 and HepG2 cells on the 24-well plates were incubated with different diameters of
Au NPs (200 μl, 50 μg/ml) for 24 h. Then, by same steps described in the previous section, the variation in the Au
mass per cell was obtained from the average Raman intensity of the peaks at 1576 cm−1 for the different sizes of Au
NPs. Second, the HL-7702 and HepG2 cells on the 24-well plates were incubated with different concentrations of
Au NPs (200 μl, 12.5, 25, 50, 100 and 200 μg/ml) for 24 h and the variation in the Au mass per cell dependent
on the concentration of the Au NPs was obtained. Instantly, the cellular uptake of the Au NPs in the HL-7702
and HepG2 cells was analyzed to determine the optimal size of the Au NPs, concentration of the Au NPs and
incubation time for further experiments.
Cytotoxicity
The cytotoxicity of the Au NPs exposed to HL-7702 and HepG2 cells was determined using the MTT assay [20–22].
First, the HL-7702 and HepG2 cells in the logarithmic phase were separately seeded on a 96-well plate at a density
of 2 × 104 cells/well as test samples. Then the cells were incubated for 12 h for the adherent growth of the cells.
Second, 40 μl of Au NPs were separately added to each well and incubated for 16 h. Similar to the above program,
the HL-7702 and HepG2 cells were incubated in Au NP-free media as the control samples. Next, 15 μl of the
MTT reagent (3.5 mg/ml) was separately added to the test and control samples and all the cells were continuously
incubated for 6 h at 37◦C. After the mixed solutions were pipetted from the 96-well plate, 150 μl of dimethyl
sulfoxide were added in each well to dissolve formazan crystals. Then, the 96-well plate was shaken by a swing bed
for 10 min at 37◦C. Finally, the absorbance of the solution in each well was measured by a microplate reader at
570 nm for evaluating the cell viability of the HL-7702 and HepG2 cells or cytotoxicity of the Au NPs.
Plasmonic photothermal therapy
Experimentally, different laser powers, irradiation times and wavelengths were used to investigate their effects on
cell viability for achieving high-efficiency PPTT. The experimental procedure is described in the following steps.
First, HL-7702 and HepG2 cells were seeded in a 96-well plate at a density of 2 × 104 cells/well and incubated
with Au NPs for 16 h. Second, the 96-well plate was irradiated by a laser beam with a focus spot diameter of
60 μm and then the irradiated cells were used as test samples, whereas the other cells away from the irradiation
were used as control samples. Here, the laser wavelengths were 532 and 785 nm. Concretely, considering the laser
wavelength of 532 nm as an example, the HL-7702 and HepG2 cells were irradiated by different powers (4, 8,
12, 16 and 20 mW) for 3 min and then the cell viability was measured by an MTT assay. Moreover, by analyzing
the cell viability, the optimal power was chosen for obtaining the largest difference between the cell viabilities of
the HL-7702 and HepG2 cells. Similarly, another group of HL-7702 and HepG2 cells was irradiated by a laser
with different exposure times (1, 2, 3, 4 and 5 min), and then their cell viabilities were measured to determine the
optimal exposure time for the largest difference between the cell viabilities of the HL-7702 and HepG2 cells.
Similarly, for the laser wavelength of 785 nm, the optimal power and exposure time were also obtained for the
largest difference between the cell viabilities of the HL-7702 and HepG2 cells.
Instruments
The SEM images were obtained by performing field-emission scanning electron microscopy (SU-70, Hitachi,
Japan) at an accelerating voltage of 5 kV. The UV–Visible absorption spectra were measured by a spectrometer
(TU1901, Pgeneral, China). Dynamic light scattering (DLS) measurements were performed with the nanoparticle
size analyzer (Zetasizer Nano S90, Malvern, UK). The thermogravimetric data was measured by a thermogravimetric
analyzer (SII TG/DTA 7300, Exstar, Japan). Raman mapping images were obtained by a Raman spectrometer (MS
3504i) which belongs to a part of a SNOM system (Ntegra Spectra, NT-MDT, Russia), with semiconductor laser
of 633 nm and 50 mW, 100 × objective lens (NA = 0.7), Al-coated grating of 1800 lines/mm and charge coupled
device detector (2048 × 2048 pixels). The Au mass was measured by ICP-MS (NexION 300X, PerkinElmer,
USA). The absorbance of the cells was recorded using a microplate reader (Dojindo, Tokyo, Japan) at 570 nm.
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Figure 1. SEM images of the Au NPs with different sizes. (A) 20 nm; (B) 30 nm; (C) 35 nm; (D) 45 nm and (E) 60 nm, which were prepared
with sodium citrate of 78, 39, 35.1, 27.3 and 19.5 μM, respectively; (F) UV-visible spectra of the Au NP solutions prepared with above
amounts of sodium citrate.
Au NP: Gold nanoparticle; SEM: Scanning electron microscopy.
The PPTT experiments were conducted individually with two lasers of 532 and 785 nm wavelengths (Raman &
FL-1705, SPL Photonics, China).
Results
Characterization of gold NPs
Various sizes of citrate-capped Au NPs were synthesized by adjusting the ratio of the citrate to HAuCl4, in reference
to Frens’ method [19]. The SEM images and absorption spectra of the Au NPs are shown in Figure 1. It is found
from Figure 1A–E that the average sizes of the Au NPs are approximately 20, 30, 35, 45 and 60 nm, respectively,
so that the size of the Au NPs increase with the decrease in sodium citrate. Figure 1F displays that the absorption
peak of the Au NPs shifts to longer wavelengths as their size increases. By comparing the absorption spectra (Figure
S1 in Supplementary material) of Au NPs and 4MBA-labeled Au NPs, it is seen that their absorption peaks have
only little red-shifts after the 4MBA was linked on the surfaces of Au NPs for same sizes of Au NPs. It presents the
4MBA-labeled Au NPs have larger sizes than that of the original Au NPs. Moreover, as the narrow size distributions
determined by (DLS) (Figure S2 in Supplementary material), the average diameters of Au NPs listed in Table S1
in Supplementary materials are consisted with the measurement of SEM images (Figure 1[A–E]).
Quantifying gold mass in cells
As described in the experiment section, Raman mapping and ICP-MS were used to quantify the Au mass in the
HL-7702 and HepG2 Cells. As an example, the SERS spectrum of the 4MBA-labeled Au NPs and the Raman
spectrum of HepG2 cell are shown in Figure 2. In Figure 2A, it is clear that the peaks at 1073 and 1576 cm-1
originate from the in-plane ring breathing mode coupled with aromatic ring ν(C-C) vibration mode of the 4MBA
molecules. In Figure 2B, the peaks at 1364 and 1393 cm-1 are ascribed to the bending vibration of CH2 of
tryptophan and vibration of CH3 of lipids in the cells, respectively [23,24]. In addition, the Raman mapping images
of the 4MBA-labeled Au NPs and HepG2 cells were recorded using the SNOM system, which are presented
in Figure 3A and C, respectively. In Figure 3A, the bright spots correspond to the strong signal of the peaks at
1576 cm-1, which indicates the aggregation of more 4MBA-labeled Au NPs [25,26]. In Figure 3C, the outlines of the
HepG2 cells are very clear owing to the presence of the CH3 bonds in all the cells. Furthermore, the self-compiled
MATLAB program was used to convert Figure 3A and C into the reproduced images with coordinates Figure 3B
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Figure 2. SERS and Raman spectra. (A) SERS spectrum of 4MBA-labeled Au NPs with a size of 35 nm and (B) Raman spectrum of HepG2
cell.
Au NP: Gold nanoparticle; 4MBA: 4-mercaptobenzoic acid; SERS: Surface-enhanced Raman scattering.
and D, respectively. That is, Figure 3B and D are the digital images of Raman mapping images. Thus, according to
the methodology described in the experiment section, by simply overlapping Figure 3B and D, the average Raman
intensity of the 4MBA molecules in a single HepG2 cell is acquired accurately to be 30500 (a. u.). Similarly,
the average Raman intensities corresponding to the other incubation times were also obtained and are shown
in Figure 4(A). The average Raman intensity of the 4MBA molecules in a single HL-7702 cell is displayed in
Figure 4B. In Figure 4, it is seen that the average Raman intensity increases with the increase in the incubation
time for both the cells. Simultaneously, the Au mass in a single HL-7702 cell and single HepG2 cell was measured
by ICP-MS. The Au mass in single HL-7702 and HepG2 cells as a function of the average Raman intensity of the
peaks at 1576 cm-1 are separately presented in Figure 5A and B, where each curve can be formulated by
y A A Ax x p   1
2 1
1 10 0[( )* ]
where y is the Au mass per cell, x is the average Raman intensity of the peaks at 1576 cm-1 and A 1, A 2, x 0, and
p are constants as listed in Table 1.
Effect of cellular uptake
The cellular uptake or cell endocytosis of NPs follows the interaction process of the NPs and cell membrane, for
which the NPs are enclosed by a portion of the cell membranes and introduced to the membrane-bound vesicle
of the cells [27–30]. First, Au NPs of various sizes and concentrations were incubated with HL-7702 and HepG2
cells for 24 h, respectively. Then the Au mass endocytosed into single HL-7702 and HepG2 cells was obtained by
measuring the average Raman intensity of the 4MBA-labeled Au NPs in the single cells with different incubation
times. Next, with a simple conversion, the number of Au NPs internalized in the HL-7702 and HepG2 cells were
easily obtained and are presented in Figure 6 A–B, respectively. From Figure 6, it is clear the number of Au NPs
in both the cells increase with the increase in the incubation time. Here, considering the unstable cellular uptake
of Au NPs, collecting data begins from 2 h, due to the fast exocytosis of Au NPs below 2 h incubation time [27].
And compared with the HL-7702 cells, the internalization of the Au NPs in the HepG2 cells rapidly saturates,
reaching a plateau. Particularly, the number of Au NPs of 35 nm size is more than that of other Au NPs, after
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Figure 3. Raman mapping images and their reproduced images. Raman mapping images of (A) 4MBA-labeled gold
nanoparticles and (C) HepG2 cells after incubation with Au NPs (35 nm, 50 μg/ml) for 16 h; (B) and (D) are the
reproduced images of (A) and (C), respectively.
Au NP: Gold nanoparticle; 4MBA: 4-mercaptobenzoic acid.
Table 1. Parameters corresponding to each curve.
y A A Ax x p   1
2 1
1 10 0[( )* ]
Cell Size A 1 A 2 x 0 p R2
HL-7702 20 nm 0.00013 0.00039 548.132 0.08587 0.97014
30 nm 0.00028 0.00149 555.133 0.10537 0.99295
35 nm 0.00044 0.02394 616.703 0.02236 0.99177
45 nm 0.00069 0.00284 548.575 0.08169 0.98358
60 nm 0.00082 0.00649 551.127 0.08601 0.99630
HepG2 20 nm -0.02518 0.00193 24310.720 284.826 0.96119
30 nm 0.00358 0.00617 28299.168 234.543 0.97259
35 nm 0.00563 0.01620 28939.480 422.784 0.98818
45 nm -0.12253 0.00555 25329.962 257.280 0.99319
60 nm -3.48358 0.01487 15350.820 1875.130 0.98451
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Figure 4. Average Raman intensity of 4MBA-labeled Au NPs as a function of the incubation time for cell. (A) Single HepG2 cell and (B)
single HL-7702 cell.
Au NP: Gold nanoparticle; 4MBA: 4-mercaptobenzoic acid.
0.0
Raman intensity (a.u.)
A
u
 m
as
s 
(n
g
)
26,000 32,000
1.8 × 10-2
2.0 × 10-3
4.0 × 10-3
6.0 × 10-3
8.0 × 10-3
1.0 × 10-2
1.2 × 10-2
1.4 × 10-2
1.6 × 10-2
27,000 28,000 29,000 30,000 31,000
20 nm
30 nm
35 nm
45 nm
60 nm
20 nm
30 nm
35 nm
45 nm
60 nm
0.0
Raman intensity (a.u.)
A
u
 m
as
s 
(n
g
)
26,500
7.0 × 10-3
1.0 × 10-3
2.0 × 10-3
3.0 × 10-3
4.0 × 10-3
5.0 × 10-3
6.0 × 10-3
27,000 27,500 28,000 28,500
Figure 5. Au mass dependence on the average Raman intensity of the peak at 1576 cm-1 in cell.(A) Single HepG2 cell and (B) single
HL-7702 cell. The data points are arranged according to the incubation time (2, 4, 6, 8. 12.16, 20 and 24 h) from left to right for each curve.
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being incubated for 12 h. This is similar to the results of previous works on citrate- and herceptin-coated Au NPs
in cells [31,32].
In addition, the relation between the cellular uptake and concentration of the Au NPs was investigated and are
separately depicted in Figure 7A and B. It is clear that the Au mass in the HL-7702 and HepG2 cells increases with
increasing incubation time and concentrations of the Au colloids, respectively. We also find that the Au uptake rate
of the HepG2 cells is higher than that of the HL-7702 cells, but it gradually reaches a plateau from the incubation
time of 12 h onward. Furthermore, there is a significant variation in the uptake rate for different types of cells. The
HepG2 cells obviously showed higher cellular uptake rate than HL-7702 cells.
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Cytotoxicity & PPTT examinations
For achieving an ideal PPTT, a direct solution is the internalization of more number of plasmonic NPs into cancer
cells and fewer number into the normal cells, resulting in a rapid death of the cancer cells and a high survival of
the normal cells. Here, based on the analysis of the cellular uptake in the previous section, Figure 8A and B display
the ratio of the Au mass in single HepG2 and HL-7702 cells for different sizes and concentrations of Au NPs,
respectively. From Figure 8A, we find that the largest ratio of Au mass is for 20 nm Au NPs and 2 h of incubation
time. However, as shown in Figure 5, the Au mass in both the cells at this time is low, which implies that a stronger
laser power or longer exposure time is needed to achieve high-efficiency PPTT. However, we also find a large ratio
of 9.08 for 35-nm-Au NPs and 16 h of incubation time and not only is the Au mass in both the cells high but
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Figure 9. Cytotoxicity of the HL-7702 and HepG2 cells evaluated by methyl thiazolyl tetrazolium assay after
incubation with gold nanoparticles for 16 hours.
the difference in the Au masses is also a maximum. Moreover, as shown in Figure 8B, although the ratio of Au
mass is large for 12.5 μg/ml of Au NP concentration and 12 h of incubation time, the Au mass in both the cells
is relatively low compared with the case of 50 μg/ml of Au NP concentration and 16 h of incubation time. Based
on the above analysis, 16 h of incubation time, 35 nm of size and 50 μg/ml of Au NP concentration are selected
as the optimal parameters for the subsequent cellular uptake experiments.
The cytotoxicity of the Au NPs is examined by an MTT assay (Table S3 in Supplementary material), and Figure 9
presents the cell viability of the HL-7702 and HepG2 cells for the above selected cellular uptake experiments [20–22].
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From Figure 9, we find that the HL-7702 and HepG2 cells exhibit high survival rates, which indicates that there
is little damage to both the cells under these specific conditions. Simultaneously, the cell viability examined by
MTT is also used to evaluate the effect of the laser on the efficiency of PPTT. Figure 10 depicts the results of the
PPTT experiments of the HL-7702 and HepG2 cells as a function of the laser power, exposure time and laser
wavelength. In Figure 10A–D, it is seen that the cell viability decreases with the increase in either the exposure
time or laser power, and the cell viability of the HL-7702 cells is typically higher than that of the HepG2 cells.
Interestingly, the cell viability of the HL-7702 cells under the different conditions is practically higher than 70%,
whereas the cell viability of the HepG2 cells is even as low as 30.8% under laser irradiation of 532 nm wavelength,
which implies that most of the HL-7702 cells survive, whereas most of the HepG2 cells get damaged. As shown in
Figures 10(E–F), the difference between the cell viabilities of both the cells exhibits a maximum at 16 mW of laser
power and 4 min of exposure time, respectively. In particular, the difference in the cell viability with irradiation of
532 nm wavelength is larger than that for irradiation of 785 nm wavelength.
Discussion
Based on the developed methodology to evaluate the cellular uptake by combining of Raman mapping and ICP-MS
techniques, two groups of calibration curves were established in Figure 5 as a function of the average Raman intensity
and the Au mass in single HL-7702 and HepG2 cells. Here, it should be pointing out that the average Raman
intensity of the peaks at 1576 cm−1 virtually depends on the number of 4MBA linked with Au NPs internalized
in single cell. Thus, thermogravimetric experiments were used to exactly quantify the number of 4MBA coated
on the Au NPs with different sizes and the result is shown in Figure S3 and Figure S4 of Supplementary material.
And from Table S2 in Supplementary material, the number (mass) of 4MBA coated on Au NPs increases as the
increase of Au NPs size. In other words, the SERS intensity of 4MBA should increase with the increase of Au NPs
size. However, as shown in Figure 5, the average Raman intensity substantially depends on the cellular uptake of
Au NPs under different conditions such as size and concentration of Au NPs, including incubation time and cell
types, which is consisted with the predicted of references [33,34]. Therefore, Figure 5 really reflects the synthesized
effect of cellular uptake of Au NPs.
Moreover, as shown in Figure 6, during the cellular uptake process, we find that the number of Au NPs in both
the cells increases from a small to large value to reach a maximum and then it decreases with the increase in the size
of the Au NPs, except for the 20 nm Au NPs. Indeed, the efficiency of cellular uptake is mainly dependent on two
factors: the amount of free energy required for wrapping the Au NPs and kinetics of the diffusion of the receptors
to the binding sites in the cell membrane. If the Au NPs have a small size, fewer receptors will bond with the Au
NPs, and consequently, less free energy will be produced to wrap the Au NPs on the surface of the cell membrane.
If the size of the Au NPs is large, more receptors will be taken up by the Au NPs, thereby affecting the kinetics of
the diffusion of the receptors to the binding sites, in other words, the receptors will be insufficient to be bound,
causing the increase of wrapping time [27]. That is why the number of 35 nm size of Au NPs is more than that of
other Au NPs in cell. And in Figure 6, the cellular uptake of the Au NPs with size of 20 nm is almost higher than
other sizes of AU NPs for entire incubation process, especially for the HL-7702 cells in the early period (before
10 h), which was also suggested by the higher internalization of small Au NPs in HeLa S3 cells [35]. This exhibits
that the cellular uptake of small Au NPs highly depends on the cell type. It can be ascribed to two reasons: one is
the wrapping of Au NPs of 20 nm size needs less free energy and so more receptors are transferred to the binding
sites of the cell membrane; the other is the higher uptake rate of Au NPs of 20 nm size causes the number of Au
NPs internalized in the HepG2 cells to reach a maximum in a short time [27,31].
In addition, Figure 7 demonstrated that a high concentration of Au colloids and/or a long incubation time
imply penetration of more number of Au NPs into the cellular membrane. Furthermore, there is a significant
variation in the uptake rate for HL-7702 and HepG2 cells. This can be attributed to the mitochondrial oxidative
phosphorylation in HL-7702 cells and aerobic glycolysis in HepG2 cells [36]. Aerobic glycolysis, also called the
Warburg effect, rapidly provides energy and much intermediate products for the uptake and proliferation of cancer
cells [37].
In PPTT experiment, the 532 nm of laser caused more damage to both cells compared with 785 nm of laser,
which can be ascribed to that the resonance absorption of 35 nm of Au NPs Figure 1F is located at 534 nm and
can convert significant heat to cause more cells death. Considering the results of laser power and exposure time,
it suggests that 16 mW of laser power, 4 min of exposure time and 532 nm of irradiation wavelength may be the
optimal experimental parameters for achieving high-efficiency PPTT.
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Conclusion
In summary, the cellular uptake of Au NPs is investigated by combining the Raman mapping and ICP-MS
techniques and the optimal parameters of the Au NPs and laser are determined for achieving high-efficiency PPTT
of HL-7702 and HepG2 cells. The results show that the mass of the Au NPs in the cells increases with increasing
incubation time, size and concentration of the Au NPs and more Au NPs with a size of 35 nm are internalized in
both the cells. Particularly, the Au mass in the HepG2 cells is much larger than that in the HL-7702 cells. This
suggests that the cellular uptake is not only affected by the size and concentration of the Au NPs but is also highly
affected by the incubation time and cell types. The optimal parameters (16 h of incubation time and 35 nm and
50 μg/ml of Au NPs) are identified for achieving a large ratio of Au mass in both the cells. Furthermore, the
optimal experimental conditions for in vitro PPTT are determined by adjusting the laser wavelength, laser power
and exposure time. This work demonstrates that the cellular uptake of the Au NPs is the most important key for
realizing high-efficiency PPTT and provides an effective guide for the development of advanced PPTT.
Future perspective
In our work, the combination of Raman and ICP-MS techniques as a novel method was proposed to quantify
the cellular uptake of Au NPs internaized in HL-7702 and HepG2 cells and an efficient PPTT was implemented
by adjusting the irradiating conditions of the laser. And many significant results have been obtained by analyzing
the role of Au NPs in experimental process, which not only confirm the biological mechanism of cellular uptake,
but also show a prior potential application in the clinical therapy of cancer. In the future, a more methodological
development of the basic technique should be achieved to effectively guide the explore in the biomedical field, such
as the tumor imaging in vitro and in vivo, drug delivery and photothermal therapy.
Executive summary
• A novel method was developed to quantify the cellular uptake of Au Nanoparticles (Au NPs) by combining
Raman mapping and Inductively-coupled plasma mass spectrometry.
• Au NPs were synthesized by an improved Frens’ method.
• The cellular uptake of the Au NPs was not only affected by their size and concentration but also by the
incubation time and cell type.
• Incubation time of 16 h and Au NPs of 35 nm and 50 μg/mL were chosen as the optimal parameters to realize a
large ratio of the Au mass in HL-7702 and HepG2 cells.
• High-efficiency Plasmonic photothermal therapy was achieved in vitro and exhibited a large difference between
the cell viabilities of the HepG2 and HL-7702 cells, which indicated a potential application prospect in the
treatment of cancer in vivo.
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